We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$28.2B
1-Year Est. Return
115.26%
This Fund
S&P 500
This Quarter
Est. Return
+19.21%
1 Year Est. Return
+115.26%
3 Year Est. Return
+356.87%
5 Year Est. Return
+474.2%
10 Year Est. Return
–
AUM
$16.5B
AUM Growth
–
Cap. Flow
+$15.4B
Cap. Flow
% of AUM
93.32%
Top 10 Holdings %
Top 10 Hldgs %
30.25%
Holding
321
New
321
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$696M |
| 2 |
Microsoft
MSFT
|
+$687M |
| 3 |
Meta Platforms (Facebook)
META
|
+$548M |
| 4 |
Amazon
AMZN
|
+$366M |
| 5 |
Advanced Micro Devices
AMD
|
+$333M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.76% |
| 2 | Healthcare | 18.36% |
| 3 | Financials | 13.71% |
| 4 | Communication Services | 11.94% |
| 5 | Consumer Discretionary | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Centene
CNC
$32.5B
| $28.5M | 0.17% |
+474,098
| New | +$30.1M |
|
|
FISV
127
Fiserv Inc
FISV
$27.9B
| $27.7M | 0.17% |
+243,343
| New | +$26.2M |
|
128
Summit Therapeutics
SMMT
$11.1B
| $27.3M | 0.17% |
+5,800,000
| New | +$24.6M |
|
129
US Foods
USFD
$24B
| $27.1M | 0.16% |
+814,626
| New | +$23.2M |
|
130
Alnylam Pharmaceuticals
ALNY
$29.3B
| $26.3M | 0.16% |
+202,000
| New | +$27M |
|
|
YMAB
131
DELISTED
Y-mAbs Therapeutics
YMAB
| $25.1M | 0.15% |
+507,633
| New | +$23.5M |
|
132
Littelfuse
LFUS
$11.6B
| $24.7M | 0.15% |
+97,014
| New | +$21.5M |
|
133
Accenture
ACN
$108B
| $24.5M | 0.15% |
+93,852
| New | +$22.5M |
|
134
Ametek
AME
$58.2B
| $24.3M | 0.15% |
+200,610
| New | +$22.6M |
|
|
CFXA
135
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $24.2M | 0.15% |
+150,000
| New | +$21.6M |
|
136
Insmed
INSM
$28.6B
| $23.3M | 0.14% |
+701,301
| New | +$25.6M |
|
137
Surgery Partners
SGRY
$2.03B
| $23.2M | 0.14% |
+799,054
| New | +$19.9M |
|
138
AtriCure
ATRC
$2.11B
| $22.9M | 0.14% |
+411,976
| New | +$17.8M |
|
139
BlackLine
BL
$1.72B
| $22.9M | 0.14% |
+171,372
| New | +$19.1M |
|
140
DexCom
DXCM
$32B
| $22.7M | 0.14% |
+245,812
| New | +$21.9M |
|
|
TRIL
141
DELISTED
Trillium Therapeutics Inc.
TRIL
| $22.5M | 0.14% |
+1,532,922
| New | +$22.1M |
|
142
Globus Medical
GMED
$11.2B
| $22.4M | 0.14% |
+342,858
| New | +$19.7M |
|
143
AptarGroup
ATR
$8.61B
| $22.3M | 0.14% |
+163,012
| New | +$20.2M |
|
144
ADC Therapeutics
ADCT
$144M
| $21.9M | 0.13% |
+683,837
| New | +$22.4M |
|
|
TMHC
145
DELISTED
Taylor Morrison
TMHC
| $21.8M | 0.13% |
+850,393
| New | +$21.7M |
|
146
Arcutis Biotherapeutics
ARQT
$3.18B
| $21.8M | 0.13% |
+775,000
| New | +$19M |
|
|
GBT
147
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $21.7M | 0.13% |
+500,000
| New | +$24.7M |
|
148
Kulicke & Soffa
KLIC
$4.78B
| $21.5M | 0.13% |
+674,849
| New | +$19.6M |
|
|
PRA
149
DELISTED
ProAssurance
PRA
| $21.3M | 0.13% |
+1,200,000
| New | +$19.6M |
|
|
SGEN
150
DELISTED
Seagen Inc. Common Stock
SGEN
| $21M | 0.13% |
+120,000
| New | +$22.4M |
|
Similar funds
N
TWC
FDCDDQ
NA
Polar Capital Holdings's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Polar Capital Holdings, which disclosed 321 positions worth $16.5B. Its ten largest holdings account for 30% of the portfolio.
Its largest position is Apple: 5,788,169 shares worth $768M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, followed by Healthcare and Financials.
- Polar Capital Holdings's largest Q4 2020 buy was Apple: 5,788,169 shares worth $768M.
- Polar Capital Holdings's ten largest holdings make up 30% of its $16.5B portfolio in Q4 2020.
- Polar Capital Holdings disclosed 321 positions in Q4 2020, its first 13F filing on record.
Based on Polar Capital Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.